1354 related articles for article (PubMed ID: 18981344)
1. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
2. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
3. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
[TBL] [Abstract][Full Text] [Related]
4. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
5. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.
Chan PS; Chow T; Kereiakes D; Schloss EJ; Waller T; Eagle K; Hayward RA; Vijan S
Arch Intern Med; 2006 Nov; 166(20):2228-33. PubMed ID: 17101941
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.
Goldenberg I; Gillespie J; Moss AJ; Hall WJ; Klein H; McNitt S; Brown MW; Cygankiewicz I; Zareba W;
Circulation; 2010 Sep; 122(13):1265-71. PubMed ID: 20837894
[TBL] [Abstract][Full Text] [Related]
8. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.
Schernthaner C; Pichler M; Strohmer B
Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140
[TBL] [Abstract][Full Text] [Related]
9. Effect of depression on mortality in implantable cardioverter defibrillator recipients--findings from the prospective LICAD study.
Tzeis S; Kolb C; Baumert J; Reents T; Zrenner B; Deisenhofer I; Ronel J; Andrikopoulos G; Ladwig KH
Pacing Clin Electrophysiol; 2011 Aug; 34(8):991-7. PubMed ID: 21438895
[TBL] [Abstract][Full Text] [Related]
10. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
[TBL] [Abstract][Full Text] [Related]
11. Psychopathology in patients with ICDs over time: results of a prospective study.
Kapa S; Rotondi-Trevisan D; Mariano Z; Aves T; Irvine J; Dorian P; Hayes DL
Pacing Clin Electrophysiol; 2010 Feb; 33(2):198-208. PubMed ID: 19930108
[TBL] [Abstract][Full Text] [Related]
12. Life after death: posttraumatic stress disorder in survivors of cardiac arrest--prevalence, associated factors, and the influence of sedation and analgesia.
Gamper G; Willeit M; Sterz F; Herkner H; Zoufaly A; Hornik K; Havel C; Laggner AN
Crit Care Med; 2004 Feb; 32(2):378-83. PubMed ID: 14758151
[TBL] [Abstract][Full Text] [Related]
13. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
[TBL] [Abstract][Full Text] [Related]
14. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
15. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
Whang W; Albert CM; Sears SF; Lampert R; Conti JB; Wang PJ; Singh JP; Ruskin JN; Muller JE; Mittleman MA;
J Am Coll Cardiol; 2005 Apr; 45(7):1090-5. PubMed ID: 15808769
[TBL] [Abstract][Full Text] [Related]
16. Intelligence and other predisposing factors in exposure to trauma and posttraumatic stress disorder: a follow-up study at age 17 years.
Breslau N; Lucia VC; Alvarado GF
Arch Gen Psychiatry; 2006 Nov; 63(11):1238-45. PubMed ID: 17088504
[TBL] [Abstract][Full Text] [Related]
17. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.
Desai H; Aronow WS; Ahn C; Tsai FS; Lai HM; Gandhi K; Amin H; Frishman WH; Kalapatapu K; Cohen M; Sorbera C
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):37-40. PubMed ID: 19966176
[TBL] [Abstract][Full Text] [Related]
18. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
[TBL] [Abstract][Full Text] [Related]
20. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
